PriceTargets.com logo

NYSE:RMED - Ra Medical Systems Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $7.00
  • Forecasted Upside: 126.54 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.09 As of 10/19/2021 01:00 AM ET
▲ +0.02 (0.65%)

This chart shows the closing price for RMED by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ra Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RMED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RMED

Analyst Price Target is $7.00
▲ +126.54% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Ra Medical Systems in the last 3 months. The average price target is $7.00, with a high forecast of $7.00 and a low forecast of $7.00. The average price target represents a 126.54% upside from the last price of $3.09.

This chart shows the closing price for RMED for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 2 polled investment analysts is to hold stock in Ra Medical Systems. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/23/2021Maxim GroupReiterated RatingBuy ➝ HoldHigh
3/17/2021Maxim GroupDowngradeBuy ➝ HoldHigh
11/29/2020Piper SandlerLower Price TargetNeutral$12.00 ➝ $7.00High
7/31/2020Piper SandlerLower Price TargetNeutral$25.00Medium
6/12/2020Maxim GroupReiterated RatingBuy$50.00Medium
5/15/2020Maxim GroupReiterated RatingBuy$75.00Medium
5/14/2020Piper SandlerLower Price TargetNeutral$37.50 ➝ $25.00Low
3/12/2020Maxim GroupReiterated RatingBuyHigh
3/11/2020Cantor FitzgeraldLower Price TargetNeutral$50.00 ➝ $37.50High
1/21/2020Piper SandlerReiterated RatingHold$37.50High
12/6/2019Maxim GroupReiterated RatingBuy$75.00Low
8/13/2019Cantor FitzgeraldDowngradeOverweight ➝ Neutral$250.00 ➝ $50.00High
8/13/2019Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$225.00 ➝ $37.50High
5/15/2019Maxim GroupLower Price TargetBuy$300.00Low
3/26/2019SunTrust BanksReiterated RatingBuy ➝ Positive$250.00Low
3/26/2019Cantor FitzgeraldReiterated RatingBuy$275.00Low
3/18/2019Cantor FitzgeraldLower Price TargetOverweight$525.00 ➝ $275.00High
3/15/2019Maxim GroupLower Price TargetBuy$375.00High
11/14/2018Cantor FitzgeraldSet Price TargetBuy$525.00Low
11/2/2018Maxim GroupInitiated CoverageBuy ➝ Buy$575.00Medium
10/22/2018Piper Jaffray CompaniesInitiated CoverageOverweight$575.00Low
10/22/2018Cantor FitzgeraldInitiated CoverageOverweight$525.00High
10/22/2018SunTrust BanksInitiated CoverageBuy$400.00High
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/24/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/22/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
7/22/2021
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2021

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Ra Medical Systems logo
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The firm's product, Pharos, is used for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. It operates through the following segments: Dermatology and Vascular. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.
Read More

Today's Range

Now: $3.09
Low: $3.01
High: $3.14

50 Day Range

MA: $3.07
Low: $2.47
High: $3.36

52 Week Range

Now: $3.09
Low: $2.38
High: $9.82

Volume

617,256 shs

Average Volume

2,188,635 shs

Market Capitalization

$21.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53

Frequently Asked Questions

What sell-side analysts currently cover shares of Ra Medical Systems?

The following equities research analysts have issued stock ratings on Ra Medical Systems in the last year: Maxim Group, Piper Sandler, and Zacks Investment Research.
View the latest analyst ratings for RMED.

What is the current price target for Ra Medical Systems?

1 Wall Street analysts have set twelve-month price targets for Ra Medical Systems in the last year. Their average twelve-month price target is $7.00, suggesting a possible upside of 126.5%. Piper Sandler has the highest price target set, predicting RMED will reach $7.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $7.00 for Ra Medical Systems in the next year.
View the latest price targets for RMED.

What is the current consensus analyst rating for Ra Medical Systems?

Ra Medical Systems currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RMED, but not buy more shares or sell existing shares.
View the latest ratings for RMED.

What other companies compete with Ra Medical Systems?

Other companies that are similar to Ra Medical Systems include enVVeno Medical, LENSAR, Femasys, Assure, Nephros, Delcath Systems, Avinger, Spectral Medical, Sensus Healthcare, STRATA Skin Sciences, Nephros, SANUWAVE Health, Aethlon Medical, NeuroMetrix and Neovasc.

How do I contact Ra Medical Systems' investor relations team?

Ra Medical Systems' physical mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company's listed phone number is (760) 804-1648 and its investor relations email address is [email protected] The official website for Ra Medical Systems is www.ramed.com.